CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale President & CEO sold 16,650 shares at $1.75 ($29,138)
- 4 Open-market sale Chief R&D Officer sold 7,355 shares at $1.75 ($12,871)
- 4 Open-market sale Chief Legal Officer sold 6,260 shares at $1.75 ($10,955)
- 4 Open-market sale 10% owner sold 56,000 shares at $1.78 ($99,630)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief R&D Officer sold 9,014 shares at $0.68 ($6,130)
- 4 Open-market sale Chief Legal Officer sold 7,606 shares at $0.68 ($5,172)
- 4 Open-market sale President & CEO sold 20,033 shares at $0.68 ($13,622)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief R&D Officer sold 9,646 shares at $0.49 ($4,727)
- 4 Open-market sale Chief Legal Officer sold 7,179 shares at $0.49 ($3,518)
- 4 Open-market sale President & CEO sold 19,877 shares at $0.49 ($9,740)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 4,359 shares at $0.69 ($3,008)
- 4 Planned sale Director sold 10,200 shares at $0.67 ($6,834)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 4,359 shares at $0.69 ($3,008)
Page 4 of 49 · 968 filings